We provide a consulting and documentation service that builds a clean substantial-equivalence (SE) story for your device, selects the correct 510(k) route (Traditional, Special, or Safety & Performance Based), and organizes everything inside FDA’s eSTAR template so it is ready for acceptance review. We do not run tests or submit on your behalf—we plan, organize, and write. For 510(k)s, eSTAR electronic submissions are required unless exempted.
Correct 510(k) route
Transparent predicate comparison
Acceptance-ready (RTA + eSTAR)
Reviewer-style wording










The 510(k) pathway still turns on substantial equivalence—but how you select the predicate, structure your comparison, and package your file in eSTAR determines how smoothly FDA can review it.
We support teams responsible for getting a 510(k) accepted and reviewed without avoidable back-and-forth.
Deliverables are centered on four outcomes: route clarity, a defensible SE comparison, evidence traceability, and an eSTAR file that is ready for acceptance review.
We move from understanding your device and options to an eSTAR-ready file with a clear SE narrative.
We focus your effort on decisions and data only you can provide.
Consulting and documentation only. We do not perform laboratory testing and do not act as the official submitter. We organize and author content; your regulatory owner submits the 510(k) to FDA via eSTAR.
Yes. For most 510(k)s, eSTAR electronic submissions are required unless FDA has granted a specific exemption. Our service delivers an eSTAR-packaged file ready for your regulatory owner to submit.
We evaluate Traditional, Special, and Safety & Performance Based Pathway options against your device, claims, changes vs. the predicate, and applicable performance criteria—then document the rationale and risks.
Only where necessary. We first use your existing verification/validation, literature, and recognized standards. Where gaps remain—for example, because of new technology or expanded claims—we highlight the tests or analyses needed to support SE.
No. Your regulatory owner or U.S. Agent remains the official submitter. We organize and author the content, package it in eSTAR, and provide a handover so they can submit confidently.
That is common. A core part of the service is the predicate & route memo, which weighs options and clarifies where a Q-Submission might be helpful before finalizing your strategy.
Technically, FDA clears a 510(k) device based on substantial equivalence to a predicate; it is not the same as a PMA approval. We avoid language that suggests formal “approval” in your 510(k) narrative.
A strong 510(k) does more than list tests—it explains clearly why your device is as safe and effective as a legally marketed predicate and packages that story in a structure FDA can review efficiently. We help you choose the right route, develop a transparent SE comparison, map evidence to claims, and deliver an eSTAR-ready file that is tuned for RTA acceptance and reviewer expectations.
We would love to speak with you.
Feel free to reach out using the below details.
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies allows us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may negatively affect certain features and functions.